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Abstract  
We examined associations between lifestyle variables and infectious disease mortality in a 
large general population cohort. A sample of 97,844 men and women (aged 47.1 ± 17.7 yrs; 
46.6% male) recruited from general population, household-based surveys were followed up 
over mean [SD] 9.4±4.5 years. Exposure measurements included self-reported physical 
activity, cigarette smoking, alcohol intake, and objective body mass index and waist to hip 
ratio. There were 9,027 deaths, of which 14.1% were attributed to infectious diseases. 
Compared to physically inactive participants both insufficiently active (Hazard ratio = 0.61; 
95% CI, 0.50, 0.75) and sufficiently active (at least 150 min/wk moderate – vigorous activity) 
(0.60; 0.45, 0.78) was associated with reduced risk of infectious disease mortality in models 
mutually adjusted for other lifestyle factors. Ex-smokers and current smokers were at 
increased risk of infectious disease mortality compared with never smoker, with the 
strongest associations being observed for heavy smoking (>20 cigarettes/day) and 
pneumonia (3.30; 2.35, 4.63). Underweight was associated with increased risk of infectious 
disease mortality (3.65; 2.64, 5.06) compared with normal weight; the risk of viral infection 
was lower in overweight (0.56; 0.44, 0.72) and obesity (0.39; 0.26, 0.58). Central obesity 
was, however, related to higher risk of bacterial infections,  but only in normal weight 
centrally obese participants (1.71; 1.10, 2.64). A physically active lifestyle and lifelong 
absence from cigarette smoking had protective associations against infectious disease 
mortality. Obesity has divergent associations dependent on peripheral and visceral fat 
depots, and the specific outcome. 
Key words: Exercise; cigarette smoking; obesity; bacterial infections; virus diseases; 
mortality 
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Introduction  
Infectious disease is becoming an increasing concern particularly in light of escalating 
microbial resistance.1,2 The sepsis incidence rate, for example, continues to rise3 and 
contributes to in excess of 5.3 million deaths per year worldwide.4 Sepsis deaths accounted 
for 7.7% of all deaths in England.5 Antimicrobial medications are often over-prescribed and 
that has led to increasing problems of antibiotic resistance. Thus, the role of lifestyle for 
prevention may become increasingly important in coming years. Few studies have assessed 
the role of multiple lifestyle factors on infection-related mortality at the population level. The 
majority of existing data have been from small clinical samples or case control studies,6 or 
considered individual lifestyle factors in isolation. 
Previous cohort studies have mostly focused on incident pneumonia,7,8 pneumonia 
mortality,9 and sepsis outcomes10,11 and suggested possible links with physical inactivity, 
cigarette smoking and obesity. For example, lower levels of physical activity were associated 
with higher risk of community-acquired sepsis,10 and pneumonia7 and pneumonia mortality9 
after accounting for other risk factors. The data on obesity, however, are inconsistent. 
Various studies have shown obesity to be both a risk factor7 and protective9 of pneumonia 
infection, and also to protect against 30-day mortality from pneumonia.12,13 In sepsis cases 
overweight, but not obesity, was associated with lower risk of mortality.6 Other cohort data 
have suggested that overweight and obesity is associated with higher risk of respiratory and 
skin infections,14 higher 30 day mortality risk after detection of blood borne bacterial 
infection,15 whilst protective against viral and fungal infections.14 The majority of obesity 
related infectious disease studies have focused on body mass index (BMI), but not 
considered central obesity both in itself and in combination with BMI. 
The aim of the present study was to examine associations between multiple lifestyle risk 
factors, obesity (both from BMI and waist measures) and infectious disease mortality in a 
large general population cohort.  
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Materials and methods 
Participants 
The Health Survey for England (HSE) and the Scottish Health Survey (SHS) are household-
based surveillance studies.16 Participants in the present study took part in one of the 
following surveys: 1994 (HSE only), 1995 (SHS only), 1997 (HSE only), 1998 (HSE and 
SHS), 1999 (HSE only), 2003 (HSE and SHS), 2004, 2006, 2008 (HSE only). The proportion 
of eligible households that took part ranged from 66% to 81%, and 91.4% of participants 
gave consent to prospective linkage with mortality records. A multistage, stratified probability 
design was used to select participants to be representative of the target populations of the 
corresponding countries. Stratification was based on geographical areas and not on 
individual characteristics: postcode (zip code) sectors were selected at the first stage and 
household addresses selected at the second stage. Local research ethics committees 
approved all aspects of each survey and all participants gave written informed consent.  
Lifestyle variables 
The questionnaires used to assess physical activity are described in detail elsewhere 
including the validity and reliability.17,18 In brief, trained interviewers enquired about the 
frequency (number of days in the last four weeks) and duration (of an average episode) of 
participation in: domestic physical activity; light-intensity (slow/average pace) and moderate-
intensity (fairly brisk/fast pace) walking; and type-specific sports and exercises. For sports 
and exercises, there was a follow-up question about relative intensity: ‘Was the effort of 
[activity] usually enough to make you out of breath or sweaty?’ A compendium19 was used to 
identify moderate- and vigorous-intensity physical activities (MVPA) in the present study: 
moderate activities were of 3.0-5.9 metabolic equivalents (METs) and vigorous activities 
were of ≥6.0 METs, where one MET is considered to represent resting energy expenditure. 
Occupational and routine domestic activities were not included in the present analysis. As 
used elsewhere20 participants were categorised as inactive (not reporting any MVPA), 
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insufficiently active (>0<150 min/week MVPA), or sufficiently active (at least 150 min/week 
MVPA).  
Interviewers also asked about cigarette smoking and alcohol intake. Participants were first 
asked, ‘Have you ever smoked a cigarette, a cigar or a pipe?’ If participants answered yes, 
they were then asked, ‘Do you smoke cigarettes at all nowadays?’ If yes, they were asked, 
‘About how many cigarettes a day do you usually smoke on weekdays?’ And, ‘About how 
many cigarettes a day do you usually smoke at weekends?’ Self-reported smoking has been 
previously validated in the present sample against objective salivary cotinine data.21 
Participants were asked if they drank alcohol nowadays, and those who said not were 
categorised as ‘never’ drinker or ‘ex-drinker’ if they used to drink and had stopped.  Drinkers 
were asked, “How often have you had an alcoholic drink of any kind during the last 12 
months?” 
Height and weight were measured to derive BMI, which was categorised as underweight 
(<18.5 kg.m-2), normal weight (18.5 – 24.99 kg.m-2), overweight (25 – 29.99 kg.m-2), obese 
stage I (30 – 34.99 kg.m-2), and obese stage II (≥35 kg.m-2).22 Waist circumference was 
recorded twice midway between the iliac crest and lower rib and hip circumference around 
the widest portion of the buttocks using measuring tape. Central obesity was defined using 
waist to hip ratio (WHR) World Health Organization criteria (WHR≥0.85 in women and 
WHR≥0.90 in men).23 
Covariates 
Age and sex were self-reported. Health status was assessed by asking participants whether 
they had ‘any longstanding illness, disability of infirmity.’ Socioeconomic status assessed 
using the Registrar General’s classification: professional and managerial occupations; 
skilled, non-manual occupations; skilled manual occupations; and, routine and manual 
occupations.  
Mortality follow-up 
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Participants were flagged by the British National Health Service Central Registry. For 
participants who survived, the data were censored up to the end of 2009 (SHS) or the first 
quarter of 2011 (HSE). Diagnoses for the primary cause of death were based on the 
International Classification of Diseases, Ninth (ICD-9) and Tenth (ICD-10) Revisions. Codes 
corresponding to infectious diseases were 001- 139 and 480-488 for ICD9 and A00-B99 and 
J09–J18 for ICD10. We further sub-typed the outcome into bacterial or viral infections, and 
pneumonia (as the organism was unspecified in all our cases). 
Statistical analysis 
Cox proportional hazards regression was used to estimate the associations of physical 
activity, smoking, alcohol and BMI (or WHR) with the risk of infectious disease mortality. The 
proportional hazards assumption was examined by comparing the cumulative hazard plots 
grouped on exposure, although no appreciable violations were noted. The timescale was 
calendar time (months). Models were adjusted for age, sex, social occupational class, 
longstanding illness and, where appropriate, mutually for cigarette smoking, alcohol, physical 
activity or BMI. Physical activity analyses were undertaken using several approaches; firstly 
the data were modelled using categories relevant to the current public health guidelines24 in 
order to optimise the relevance of our results for policy makers; second, we used the data in 
a continuous format derived from total MET hours in order to examine dose-response 
relationships in more detail. In a sensitivity analysis, we excluded those who died during the 
first 24 months of follow-up and those reporting limiting long standing illnesses to explore 
possible effects of reverse causation. We conducted analyses stratified by the median length 
of follow up (10.7 yrs; surveys before year 2000 and later survey years 2000 onwards) to 
examine possible measurement dilution bias in surveys less proximal to the outcome.   We 
also examined combinations of BMI/WHR in relation to infectious disease mortality. All 
analyses were performed using SPSS version 22 (IBM Inc.). 
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Results  
The sample comprised 97,844 participants (aged 47.1 ± 17.7 yrs; 46.6% male).  During 
919,949 person years of follow up (mean [SD] 9.4±4.5 yr; range 0 – 17 years) there were 
9,027 deaths, of which 14.1% were attributed to infectious diseases. Participants dying from 
infectious disease were older than those dying from other causes, contained a greater 
proportion of ex-smokers, a higher proportion of never and ex-drinkers, were more physically 
inactive, reported more prevalent disease, and tended to be from lower social classes (Table 
1). 
Physical activity (both insufficient and sufficiently active) was associated with ~40% reduced 
risk of infectious disease mortality in models adjusted for all covariates (Table 2). We 
explored the dose-response relationship in more detailed sensitivity analyses (Table e1), 
which suggested there may be an “L”-shaped association between physical activity and risk 
of infectious disease mortality (i.e, an initial linear reduction in risk with increasing activity, 
followed by a flattening of the curve at higher levels). Similar patterns emerged when we 
examined bacterial and viral infections separately, although associations were far weaker for 
pneumonia mortality (Table 3). 
Underweight was associated with increased risk of infectious disease mortality (hazard ratio 
[HR] =3.65, 95% CI, 2.64, 5.06) compared with normal weight (Table 2), and associations 
were consistent for both bacterial and viral outcomes, albeit strongest for pneumonia 
mortality (HR=4.28; 2.56, 7.15) (Table 3). Overweight and stage I obesity were associated 
with reduced risk of infectious disease mortality compared with normal weight (Table 2) and 
these associations became marginally stronger for obesity when models were adjusted for 
all covariates. The protective associations with overweight (HR=0.56; 0.44, 0.72) and stage I 
obesity (HR=0.39; 0.26, 0.58) were particularly strong for viral infections although were 
absent in the case of bacterial infection (Table 3). We conducted a separate analysis using 
participants with available data on WHR (n=68,205; events=941). There were no 
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associations between central obesity and all infectious disease mortality (fully adjusted 
HR=0.96; 0.83 – 1.10). We did, however, observe associations for bacterial infection 
(HR=1.41; 1.01, 1.88), but not viral (HR=0.98; 0.74, 1.30) or pneumonia mortality (HR=0.90; 
0.73, 1.11). We further examined associations between combinations of BMI categories and 
central obesity with infectious disease mortality (Table e2) and found increased risk of 
bacterial infection only in normal weight centrally obese (HR=1.71; 1.10, 2.64). A reduced 
risk of viral infection mortality was found in all overweight and obese BMI categories 
regardless of central obesity. 
We observed consistent associations between ex-smokers and current smokers with 
increased risk of infectious disease mortality compared with never smoker, although no clear 
dose-response pattern emerged with smoking volume (Table 2).  Similar patterns of results 
emerged in analyses of bacterial and viral infection, although heavy smoking appeared to be 
a greater risk factor for viral infection (HR=2.67; 1.52, 4.11) and pneumonia (HR=3.30; 2.35, 
4.63) as oppose to bacterial infections (HR=1.41; 0.87, 2.31) (Table 3). We found no 
associations between alcohol intake and infectious disease mortality  (Table 2), albeit 
marginally increased risk of pneumonia in ex-drinkers (HR=1.50; 1.00, 2.24) (Table 3). In a 
sub-sample of participants (n=48,045; events=1058) with available data on alcohol volume 
(calculated by summing the units of each type of beverage and multiplying by the frequency) 
we did not detect any associations between hazardous or harmful drinking and infectious 
disease mortality (Table e3). 
In sensitivity analyses we removed deaths occurring in the first 2 years of follow up but the 
results were not appreciably changed (Table e4). We repeated our analyses after removal of 
participants (n=37,557) who reported “limiting” longstanding illness (Table e5), although 
results were largely unchanged, albeit some associations were difficult to interpret with 
limited events in some groups. Although behaviours such as smoking and physical activity 
remain relatively stable in adulthood, body weight is more likely to fluctuate thus 
measurement bias is possible for exposures assessed less proximal from the outcome. Thus 
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we compared results from the earlier surveys (up to maximum 17 years follow up) with those 
from later survey years (with up to maximum of 10 years follow up). In general there were 
few differences (Table e6), except effect estimates for underweight were greater in the more 
recent surveys with shorter follow up.  
 
Discussion  
The aim of the present study was to examine associations between lifestyle risk factors and 
infectious disease mortality. The main findings suggest physical activity, never smoking, and 
overweight/obesity were protective against infectious disease mortality. There have been 
few community based cohort studies large enough to examine infection related mortality in 
the general population, and those that have specifically focused on pneumonia7-9 or bacterial 
infections.15 
Previous work in population cohorts has demonstrated associations between physical 
activity and lower risk of community acquired pneumonia,7,9, sepsis,10,11 and 30 day mortality 
after detection of blood borne bacterial infection.15 A large amount of work exists on exercise 
and immunity25 that has described a “J” shaped association between exercise and infection 
with optimal protection at moderate levels of activity. Nevertheless, this body of work has 
been traditionally based on convenience samples or elite athlete populations with soft end 
points such as upper respiratory tract infections.26-28 Thus, the present study adds 
substantially by examining associations in a large representative sample with a full spectrum 
of activity levels and hard endpoint. We did not find the “J” or “U” shaped associations 
described previously, instead we observed an “L”-shaped pattern, although infectious 
disease events were limited in the very highly active. The protective associations were seen 
even at very low levels of activity far below the current guidelines (i.e., between 1 – 3 MET-
hr-wk, equivalent to moderate intensity walking for 30 min per week). Our results are highly 
congruent with the new 2018 US physical activity guidelines that place increased emphasis 
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on physical activity of any intensity and recognise the health benefits of doses below the 
recommended levels.29 
Plausible biological mechanisms exist explaining the immunological benefits of exercise,25 
for example, we previously observed inverse associations between physical activity and 
circulating inflammatory markers in the present cohort.30 A body of evidence also suggests 
that exposure to either acute or chronic exercise significantly augments the immune 
response to vaccination.31 
The existing evidence on obesity and infection are equivocal, although data from large 
cohort studies with substantial follow up has been lacking. Recent studies,9,14,15 notable for 
their large sample sizes and robust outcomes, all demonstrated increased risk of infection in 
the underweight that is consistent with our data. Inuoe et al.9 showed that BMI above 25 
kg.m-2 was protective against pneumonia mortality; Harpsøe et al.14 suggested that 
overweight and obesity was associated with higher risk of respiratory and skin infections 
whilst protective against viral and fungal infections; Paulsen et al.15 showed that all levels of 
BMI defined obesity were associated with higher 30 day mortality risk after detection of blood 
borne bacterial infection. Thus, our results are largely consistent with these findings 
suggesting reduced risk of viral infection and pneumonia mortality in overweight/obese when 
defined from BMI. There are presently limited data on central obesity; recent evidence 
showed central obesity to be associated with a 1.7-fold increased risk of sepsis mortality.11 
We extended these findings by examining the combination of BMI (peripheral obesity) and 
central obesity, and showed central obesity was associated with increased risk of bacterial 
infection, particularly in the normal weight centrally obese.  The mechanisms behind the 
obesity paradox are poorly understood, but there may be several explanations. Firstly, 
infections are often acute illnesses and nutritional reserve provided by excess adiposity may 
aid survival during a life-threatening period.32 We generally observed protective associations 
with BMI but not WHR, and although it is known that peripheral and visceral fat depots differ 
in morphology and function33 little is known about specific effects on immunity. Second, 
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obese participants may have greater contact with primary care, and some data suggest 
greater use of antibiotics in this group,34 which would help treat and diagnose infections 
more quickly avoiding more serious outcomes such as hospitalisation and death. We did not 
capture infections treated outside hospital settings thus were unable to explore this issue in 
more depth. Lastly, there remains the possibility of reverse causation whereby initially obese 
participants who contract infections lose weight and effectively contaminate the normal 
weight referent category.35 Although our results were unchanged in sensitivity analysis that 
removed early deaths, we did not have weight histories to properly examine this issue. 
Our data showed that heavy smoking was a particularly strong risk factor for pneumonia, 
which is consistent with increasing recognition of smoking-related lung diseases other than 
lung cancer and chronic obstructive pulmonary disease.36,37 We also observed increased 
risks of all types of infections in ex-smokers suggesting that tobacco may have long lasting 
effects. The mechanisms have been largely connected to the inflammatory effects of 
tobacco smoke36 although remain incompletely understood. We found no associations 
between alcohol consumption and risk of infectious disease that replicates other findings.15 
The effects of lifestyle risk factors on infection risk may also operate through intermediate 
disease pathways, such as diabetes and cardiovascular disease, which are associated with 
both poor lifestyle and increased risk of infections.38,39 That the associations between 
underweight and infection became stronger in surveys more proximal to the outcome 
suggests a role of underlying diseases that may contribute to both weight loss and increased 
risk of infections. 
The key strengths of this study include the inclusion of a large population sample, validated 
exposure measures (including objective assessment of obesity), and the ability to examine 
mortality attributed to both bacterial and viral infections. The main limitation was that we 
were unable to objectively verify specific infections through positive blood culture and ICD 
codes are often limited regarding the specific organisms. Nevertheless, the overall 
proportion of the sample dying from bacterial infection (~0.4%) in our study was similar to 
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other European data that was verified through blood cultures.15 The absence of data on non-
mortality related infection is a limitation of the study and our outcome likely reflects the most 
severe cases. Nevertheless, similar trends have been observed for non-mortality related 
infection7 and infections resulting in death9 relative to lifestyle risk factors. Other limitations 
include the possibility of residual confounding as we lacked complete data on other lifestyle 
variables (e.g., sedentary behaviour, diet). Physical activity was self-reported thus subject to 
recall bias, and did not include detailed questions on occupational activity. BMI has been 
criticised as a measure of obesity. Nevertheless, BMI remains a robust predictor of major 
causes of death in large scale population studies40 and is a useful tool for detecting targeted 
metabolic traits when compared to direct measures of fat mass (such as Dual-energy X-ray 
absorptiometry).41 
In summary, we observed associations between various lifestyle risk factors and infectious 
disease mortality in a large general population cohort. In light of escalating microbial 
resistance, healthy lifestyles should be promoted to improve resilience against infectious 
diseases. These findings will be important to inform future public health policy and assist 
physicians in clinical decisions to help improve resilience to infection.
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Table 1. Baseline characteristics according to death status 
Variable at baseline Alive  Death from other 
causes 
Death from 
infectious disease 
N 88817 7753 1274 
Age (yrs, SD) 
 
44.9± 16.1 66.9± 13.1 73.0± 10.9 
Sex (% men) 
 
46.1 52.3 51.1 
Cigarette Smoking (%) 
Never 
Ex-smoker  
Light, <10/d 
Medium,10-19/d 
Heavy,≥20/d 
 
49.4 
23.7 
7.5 
11.0 
8.5 
 
31.9 
38.8 
5.8 
11.0 
12.4 
 
31.8 
45.2 
7.7 
8.1 
7.2 
Alcohol, frequency (%) 
Never 
Ex-drinker  
< monthly 
1 – 2 / month 
1 – 4 /week 
≥5 /week 
 
6.3 
3.5 
13.6 
13.2 
46.2 
17.2 
 
6.6 
8.1 
17.5 
10.5 
33.9 
23.4 
 
9.3 
9.2 
19.2 
9.5 
29.7 
23.1 
Physical activity (%) 
Inactive 
Insufficiently active 
Sufficiently active 
 
47.9 
29.4 
22.7 
 
80.8 
12.7 
6.5 
 
86.9 
8.7 
4.4 
Body mass index category 
Underweight  
Normal  
Overweight  
Stage I obese 
Stage II obese 
 
0.7 
39.4 
38.6 
15.3 
5.9 
 
1.4 
34.5 
40.8 
17.1 
6.1 
 
3.1 
38.0 
39.8 
14.2 
4.9 
Longstanding illnesses 
(%)  
41.1 67.6 72.8 
Professional occupations 
(%) 
4.9 3.1 2.1 
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Table 2. Lifestyle risk factors and infectious disease mortality (N=97,844) 
Risk factor  N Deaths Model 1 
Hazard Ratio  
(95% CI) 
 
Model 2 
Hazard Ratio  
(95% CI) 
 
Physical activity     
Inactive  49,960 1107 1.00 (Ref) 1.00 (Ref) 
Insufficient 27,207 107 0.54 (0.34, 0.56) 0.61 (0.50, 0.75) 
Sufficiently active 20,677 56 0.51 (0.39, 0.67) 0.60 (0.45, 0.78) 
     
Body mass index 
category 
    
Underweight  805 40 4.07 (2.94, 5.62) 3.65 (2.64, 5.06) 
Normal  38,193 484 1.00 (Ref) 1.00 (Ref) 
Overweight  37,969 507 0.71 (0.63, 0.80) 0.72 (0.63, 0.81) 
Stage I obese 15,125 181 0.72 (0.60, 0.85) 0.69 (0.58, 0.82) 
Stage II obese 5,752 62 0.92 (0.70, 1.20) 0.82 (0.63, 1.07) 
     
Cigarette 
smoking 
    
Never 46,713 405 1.00 (Ref) 1.0 (Ref) 
Ex-smoker  24,604 576 1.46 (1.28, 1.67) 1.46 (1.28, 1.67) 
Current, <10/d 7,235 98 2.57 (2.06, 3.20) 2.26 (1.81, 2.82) 
Current, 10-19/d 10,720 103 2.32 (1.86, 2.89) 1.91 (1.53, 2.39) 
Current, ≥20/d 8,565 92 2.96 (2.34, 3.74) 2.43 (1.91, 3.08) 
     
Alcohol 
frequency 
    
Never 6,190 119 1.00 (Ref) 1.0 (Ref) 
Ex-drinker  3,831 117 1.46 (1.18, 1.88) 1.24 (0.96, 1.61) 
< monthly 13,614 244 0.99 (0.80, 1.23) 0.96 (0.77, 1.19) 
1 – 2 / month 12,624 121 0.84 (0.65, 1.08) 0.88 (0.68, 1.14) 
1 – 4 /week 43,859 378 0.86 (0.70, 1.06) 0.89 (0.72, 1.10) 
≥5 /week 17,303 294 0.91 (0.73, 1.13) 0.94 (0.76, 1.19) 
Model 1: adjusted for age and sex 
Model 2: adjusted for age, sex, longstanding illness, social occupational status, and mutually for 
physical activity, BMI category, cigarette smoking, alcohol. 
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Table 3. Lifestyle risk factors and infectious disease mortality stratified by bacterial or viral 
origin.  
Risk factor  Bacterial 
Hazard Ratio  
(95% CI) 
(369 deaths) 
Viral 
Hazard Ratio  
(95% CI) 
(326 deaths) 
Pneumonia 
Hazard Ratio  
(95% CI) 
(579 deaths) 
Physical activity    
Inactive 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Insufficient 0.57 (0.39, 0.82) 0.36 (0.21, 0.60) 0.80 (0.61, 1.04) 
Sufficiently active 0.46 (0.27, 0.79) 0.48 (0.26, 0.88) 0.76 (0.52, 1.11) 
    
Body mass index 
category 
   
Underweight  2.34 (1.09, 5.03) 3.82 (2.30, 6.35) 4.28 (2.56, 7.15) 
Normal  1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Overweight  0.86 (0.68, 1.09) 0.56 (0.44, 0.72) 0.73 (0.61, 0.88) 
Stage I obese 0.91 (0.67, 1.24) 0.39 (0.26, 0.58) 0.75 (0.58, 0.96) 
Stage II obese 0.91 (0.56, 1.48) 0.76 (0.47, 1.23) 0.81 (0.53, 1.24) 
    
Cigarette 
Smoking 
   
Never 1.00 (Ref) 1.0 (Ref) 1.0 (Ref) 
Ex-smoker  1.43 (1.12, 1.82) 1.52 (1.17, 1.99) 1.45 (1.19, 1.76) 
Light, <10/d 2.49 (1.68, 3.68) 2.58 (1.70, 3.93) 1.95 (1.37, 2.78) 
Medium,10-19/d 1.85 (1.24, 2.76) 2.17 (1.43, 3.29) 1.83 (1.29, 2.61) 
Heavy,≥20/d 1.41 (0.87, 2.31) 2.67 (1.51, 4.11) 3.30 (2.35, 4.63) 
    
Alcohol 
frequency 
   
Never 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Ex-drinker  1.10 (0.68, 1.77) 1.11 (0.68, 1.80) 1.50 (1.00, 2.24) 
< monthly 0.83 (0.55, 1.25) 0.87 (0.58, 1.31) 1.14 (0.81, 1.61) 
1 – 2 / month 0.72 (0.45, 1.16) 0.68 (0.41, 1.14) 1.17 (0.80, 1.72) 
1 – 4 /week 0.77 (0.52, 1.14) 0.87 (0.58, 1.29) 1.02 (0.73, 1.43) 
≥5 /week 0.81 (0.54, 1.22) 0.85 (0.56, 1.28) 1.12 (0.80, 1.59) 
Models adjusted for age, sex, longstanding illness, social occupational status, and mutually for 
physical activity, BMI category, cigarette smoking, alcohol.  
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Supplementary analyses 
Table e1. Dose response pattern between physical activity and infectious disease mortality. 
Physical activity 
(MET-hr-wk) 
N Deaths Hazard Ratio  
(95% CI)1 
 
Total (non-
occupational)  
   
<1.6 16,533 591 1.00 (Ref) 
1.6 – 9  22,265 296 0.68 (0.59, 0.79) 
9.1 – 19  19,548 164 0.55 (0.46, 0.66) 
19.1 – 37.5  19,847 117 0.44 (0.36, 0.54) 
>37.5 19,619 105 0.55 (0.44, 0.68) 
    
Sports & exercise    
0 51,557 1066 1.00 (Ref) 
1 – 3  9,795 66 0.74 (0.58, 0.96) 
3.1 – 9  12,913 71 0.64 (0.50, 0.82) 
9.1 – 21  11,490 37 0.51 (0.36, 0.71) 
>21 12,074 34 0.66 (0.47, 0.93) 
1Model adjusted for age, sex, longstanding illness, social occupational status, BMI category, smoking, 
alcohol. 
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Table e2. The association of combinations of BMI categories and central obesity with 
infectious disease mortality (N=68,205). 
BMI/ WHR groups HR (95% CI)  
All infections  
(941 events) 
HR (95% CI)  
Bacterial infections 
(268 events) 
HR (95% CI)  
Viral infections  
(244 events) 
HR (95% CI)  
Pneumonia  
(429 events) 
Normal weight, 
without central obesity 
1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 
Normal weight + 
central obesity 
1.20 (0.97, 1.49) 1.71 (1.10, 2.64) 1.08 (0.73, 1.58) 1.08 (0.78, 1.48) 
Overweight without 
central obesity 
0.79 (0.63, 1.00) 1.04 (0.64, 1.69) 0.56 (0.35, 0.90) 0.83 (0.60, 1.15) 
Overweight, + central 
obesity 
0.85 (0.70, 1.02) 1.27 (0.86, 1.88) 0.68 (0.48, 0.97) 0.80 (0.59, 1.03) 
Obese  without central 
obesity 
0.68 (0.49, 0.96) 0.85 (0.42, 1.71) 0.21 (0.10, 0.58) 0.97 (0.62, 1.50) 
Obese, + central 
obesity 
0.83 (0.66, 1.03) 1.42 (0.93, 2.16) 0.53 (0.34, 0.83) 0.76 (0.54, 1.07) 
Models adjusted for age, sex, longstanding illness, social occupational status, physical activity, 
smoking, alcohol. 
Underweight were excluded from these analyses. 
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Table e3. The association between alcohol volume and infectious disease mortality 
(N=48,045). 
Alcohol group HR (95% CI)  
All infections  
(1058 events) 
HR (95% CI)  
Bacterial infections 
(322 events) 
HR (95% CI)  
Viral infections  
(320 events) 
HR (95% CI)  
Pneumonia  
(416 events) 
Never  
 
1.0 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Ex-drinker 
 
1.23 (0.87, 1.76) 1.43 (0.76, 2.67) 1.20 (0.66, 2.19) 1.14 (0.62, 2.11) 
Drinker, but not in last 
7 days 
0.84 (0.65, 1.07) 0.70 (0.44, 1.12) 0.87 (0.57, 1.33) 0.93 (0.62, 1.41) 
Drinker, within 
guidelines1 
0.77 (0.54, 1.10) 0.81 (0.42, 1.57) 0.73 (0.40, 1.36) 0.73 (0.41, 1.30) 
Hazardous drinking2 
 
0.80 (0.53, 1.21) 0.84 (0.40, 1.76) 0.94 (0.46, 1.92) 0.64 (0.32, 1.26) 
Harmful drinking3 
 
0.99 (0.59, 1.68) 1.37 (0.58, 3.25) 1.22 (0.49, 3.05) 0.47 (0.17, 1.34) 
Models adjusted for age, sex, longstanding illness, social occupational status, physical activity, 
smoking, BMI. 
1Alcohol guidelines; <21 units/wk men, <14 units/wk women; 2Hazardous; 21- 49 units/wk men; 14-35 
units/wk women; 3 Harmful; > 49 units/wk men; >35 units/wk women. Total weekly alcohol units were 
calculated by summing the units of each type of beverage and multiplying by the frequency. In the 
UK, one unit is eight grammes of alcohol, which roughly corresponds to a 25 ml measure of spirits or 
a half-pint of beer; And, a 175 mL glass of wine contains two units of alcohol. 
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Table e4. Lifestyle risk factors and infectious disease mortality removing early deaths in first 
2 years of follow up (N=96,348) 
Risk factor  N Deaths Hazard Ratio  
(95% CI)1 
 
Physical activity    
Inactive 48,794 882 1.00 (Ref) 
Insufficient  27,017 92 0.63 (0.51, 0.78) 
Sufficiently active 20,542 48 0.65 (0.49, 0.88) 
    
Body mass index 
category 
   
Underweight  769 27 3.62 (2.44, 5.36) 
Normal  37,597 376 1.00 (Ref) 
Overweight  37,421 420 0.76 (0.66, 0.87) 
Stage I obese 14,894 151 0.75 (0.62, 0.91) 
Stage II obese 5,672 48 0.85 (0.63, 1.15) 
    
Smoking    
Never 46,250 329 1.0 (Ref) 
Ex-smoker  24,012 462 1.47 (1.27, 1.70) 
Light, <10/d 7,122 77 2.24 (1.75, 2.88) 
Medium,10-19/d 10,550 75 1.82 (1.41, 2.36) 
Heavy,≥20/d 8,419 79 2.76 (2.13, 3.58) 
    
Alcohol 
frequency 
   
Never 6,092 96 1.0 (Ref) 
Ex-drinker  3,682 79 1.08 (0.80, 1.46) 
< monthly 13,344 198 0.97 (0.76, 1.24) 
1 – 2 / month 12,485 102 0.92 (0.69, 1.22) 
1 – 4 /week 43,373 303 0.88 (0.70, 1.12) 
≥5 /week 16,966 243 0.97 (0.76, 1.25) 
  
1Model adjusted for age, sex, longstanding illness, social occupational status, and mutually either for 
physical activity, BMI category, smoking, alcohol. 
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Table e5. Lifestyle risk factors and infectious disease mortality removing participants with 
limiting long standing illness (N=60,287) 
Risk factor  N Deaths Hazard Ratio  
(95% CI)1 
 
Physical activity    
Inactive 26,450 250 1.00 (Ref) 
Insufficient  18,292 35 0.67 (0.47, 0.97) 
Sufficiently active 15,545 33 0.91 (0.63, 1.32) 
    
Body mass index 
category 
   
Underweight  453 9 3.59 (1.80, 7.15) 
Normal  24,159 131 1.00 (Ref) 
Overweight  23,685 125 0.63 (0.50, 0.81) 
Stage I obese 8,891 38 0.57 (0.40, 0.83) 
Stage II obese 3,099 15 1.06 (0.61, 1.82) 
    
Smoking    
Never 30,846 117 1.0 (Ref) 
Ex-smoker  13,916 121 1.10 (0.84, 1.44) 
Light, <10/d 4,624 20 1.78 (1.10, 2.87) 
Medium,10-19/d 6,390 32 2.08 (1.39, 3.12) 
Heavy,≥20/d 4,511 28 2.86 (1.85, 4.43) 
    
Alcohol 
frequency 
   
Never 3,870 30 1.0 (Ref) 
Ex-drinker  1,696 23 1.13 (0.65, 1.96) 
< monthly 7,467 55 0.90 (0.58, 1.42) 
1 – 2 / month 7,722 28 0.79 (0.47, 1.33) 
1 – 4 /week 28,420 110 0.93 (0.61, 1.42) 
≥5 /week 11,112 72 0.86 (0.55, 1.34) 
  
1Model adjusted for age, sex, longstanding illness, social occupational status, and mutually either for 
physical activity, BMI category, smoking, alcohol. 
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Table e6. Lifestyle risk factors and infectious disease mortality stratified by survey year (pre  
vs. post 2000) 
Risk factor  Hazard Ratio  
(95% CI) 
Early surveys1 
(n=54,390; events=1077) 
Hazard Ratio  
(95% CI) 
Later surveys2 
(n=43,437; events=197) 
Physical activity   
Inactive 1.00 (Ref) 1.00 (Ref) 
Insufficient  0.64 (0.52, 0.80) 0.54 (0.31, 0.94) 
Sufficiently active 0.63 (0.47, 0.85) 0.57 (0.28, 1.18) 
   
Body mass index 
category 
  
Underweight  3.13 (2.14, 4.58) 5.75 (2.99, 11.04) 
Normal  1.00 (Ref) 1.00 (Ref) 
Overweight  0.75 (0.65, 0.86) 0.67 (0.48, 0.93) 
Stage I obese 0.74 (0.61, 0.89) 0.61 (0.40, 0.95) 
Stage II obese 0.97 (0.72, 1.30) 0.61 (0.31, 1.19) 
   
Smoking   
Never 1.00 (Ref) 1.0 (Ref) 
Ex-smoker  1.44 (1.24, 1.66) 1.47 (1.06, 2.04) 
Light, <10/d 2.32 (1.84, 2.93) 0.96 (0.38, 2.09) 
Medium,10-19/d 1.84 (1.44, 2.34) 2.13 (1.21, 3.77) 
Heavy,≥20/d 2.29 (1.76, 2.97) 3.07 (1.69, 5.05) 
   
Alcohol 
frequency 
  
Never 1.00 (Ref) 1.00 (Ref) 
Ex-drinker  1.18 (0.89, 1.56) 1.85 (0.90, 3.77) 
< monthly 0.91 (0.72, 1.16) 1.58 (0.85, 2.93) 
1 – 2 / month 0.88 (0.67, 1.16) 1.03 (0.49, 2.15) 
1 – 4 /week 0.90 (0.72, 1.13) 0.93 (0.50, 1.76) 
≥5 /week 0.93 (0.74, 1.19) 1.23 (0.66, 2.32) 
Model  adjusted for age, sex, longstanding illness, social occupational status, and mutually either for 
physical activity, BMI category, smoking, alcohol. 
1Includes 1994 (HSE only), 1995 (SHS only), 1997 (HSE only), 1998 (HSE and SHS), 1999 (HSE 
only); 2Includes 2003 (HSE and SHS), 2004, 2006, 2008 (HSE only). 
 
 
